Andromeda - OmicsDI

Show results for

Proteomics (5185)
Unknown (53)
Genomics (9)

Organisms

Allexis (5161)
Arabidopsis thaliana (5161)
Homo sapiens (5161)
Mus musculus (5161)
Rattus norvegicus (5161)
Saccharomyces cerevisiae (5161)
Shigella (5161)
Shigella flexneri (5161)
Listeria monocytogenes (5160)
Schizosaccharomyces pombe (5160)
Entamoeba histolytica HM-1:IMSS-A (5159)
Escherichia coli (5159)
Solanum tuberosum (5159)
Staphylococcus aureus (5159)
Sus scrofa domesticus (5159)
Medicago truncatula (5158)
Sinorhizobium meliloti BL225C (5158)
Zea mays (5158)
Meleagris gallopavo (5157)
Methylohalobius crimeensis 10Ki (5157)
Bos taurus (5155)
Leishmania major strain Friedlin (5155)
Callinectes sapidus (5154)
Drosophila melanogaster (5153)
Pseudomonas fluorescens WH6 (5151)
Homo sapiens (2)
Mus musculus (2)
Hordeum vulgare (1)
Haloferax volcanii DS2 (1)
cellular organisms (1)

Organisms

Cassiopea andromeda (3)
Homo sapiens (1)

Repository

pride (5162)
MassIVE (17)
ENA (8)
iProX (4)
jPOST (2)
geo (1)

Tissue

Cell culture (1167)
Epithelial cell (386)
Brain (252)
Permanent cell line cell (221)
Liver (162)
Fibroblast (144)
Blood (133)
Leaf (131)
Plant cell (124)
T cell (108)
Lung (102)
Kidney (99)
Heart (94)
Blood plasma (93)
Blood cell (88)
Macrophage (87)
Whole body (83)
Cell suspension culture (80)
Embryonic stem cell (78)
Colon (77)
Spleen (64)
Primary cell (63)
HeLa cell (61)
Bone marrow (60)
Stem cell (55)
Hepatocyte (52)
B cell (51)
Skin (46)
Embryo (44)
Root (42)

Disease

Breast cancer (154)
Disease free (137)
Colon cancer (99)
Acute leukemia (71)
Cervix carcinoma (45)
Malignant neoplasm of ovary (36)
Prostate adenocarcinoma (29)
Lung cancer (27)
Brain cancer (26)
Melanoma (26)
Cardiovascular system disease (25)
Neuroblastoma (24)
Plasmodium falciparum malaria (22)
Amyotrophic lateral sclerosis (20)
Non-small cell lung carcinoma (20)
Alzheimer's disease (19)
Type 2 diabetes mellitus (19)
Brain glioblastoma multiforme (16)
Hepatocellular carcinoma (16)
Huntington Disease (16)
COVID-19 (15)
Pancreatic ductal adenocarcinoma (15)
Lymphoma (14)
Glioblastoma (13)
Influenza (13)
Osteosarcoma (13)
Parkinson's disease (13)
Pancreatic cancer (12)
Prostate cancer (12)
Cystic fibrosis (11)

Technology Type

Mass Spectrometry (5162)
Shotgun proteomics (3454)
Affinity purification coupled with mass spectrometry proteomics (855)
Bottom-up proteomics (802)
Data-dependent acquisition (571)
Gel-based experiment (306)
Top-down proteomics (102)
Data-independent acquisition (50)
SWATH MS (44)
SRM/MRM (40)
Affinity proteomics (30)
Chemical cross-linking coupled with mass spectrometry proteomics (28)
Proteogenomics (9)
All-ion fragmentation (8)
DiaPASEF (6)
HDMSE (4)
Mass spectrometry imaging (3)
MSE (2)
Metaproteomics (2)
Glycoproteomics (1)

Instrument Platform

Q Exactive (3)
LTQ Orbitrap (2)
LTQ Orbitrap Elite (2)
Orbitrap Eclipse (2)
Orbitrap Fusion (2)
Q Exactive Plus (2)
LTQ Orbitrap Velos (1)
MaXis (1)
Orbitrap Exploris 480 (1)
Orbitrap Fusion ETD (1)
Q-Exactive Plus Orbitrap mass spectrometer (1)

First Public Date

2023 (3)
2019 (2)
2026 (1)
2024 (1)
2020 (1)

Modification

2x(15)N labeled L-lysine (16)
4x(15)N labeled L-arginine (14)
N6 (10)
N6-dimethyl-L-lysine (7)
4-tetrahydrothiazine-3-carboxylic acid (4)
4x(2)H labeled dimethylated residue (4)
15.994915 (3)
57.021464 (3)
+3amu) (2)
-17.026549 (2)
-18.010565 (2)
42.010565 (2)
Not available (2)
3x(2)H labeled N6-acetyl-L-lysine (1)
4 (1)
79.966331 (1)

Release Date

2020 (12)
2023 (10)
2022 (6)
2025 (5)
2021 (5)
2024 (3)
2019 (3)
2018 (3)
2026 (2)
2017 (2)
2016 (1)
2011 (1)

Lab affiliation

Wageningen University (60)
Analytics Core Facility Essen (ACE), Chemische Biologie, Universität Duisburg-Essen, ZMB, Germany (47)
University of Vienna, Faculty of Chemistry, Department of Analytical Chemistry (35)
Basic Immune System of Plants / Protein Mass Spectrometry Max Planck Institute for Plant Breeding Research Carl-von-Linne-Weg 10, 50829 Cologne, Germany (34)
University of Edinburgh (29)
Department of Biochemistry and Functional Proteomics, Institute of Biology II, Faculty of Biology and BIOSS Centre for Biological Signalling Studies, University of Freiburg, 79104 Freiburg im Breisgau, Germany (28)
CRUK - Beatson Institute for Cancer Research - Switchback Rd, Bearsden, Glasgow G61 1BD - United Kingdom (24)
Chair of Biochemistry II, Theodor Boveri-Institute, Biocenter, University of Würzburg, Würzburg, Germany (24)
Amsterdam UMC, Vrije Universiteit Amsterdam, Medical Oncology, Cancer Center Amsterdam, OncoProteomics Laboratory, Amsterdam, Netherlands (20)
Institute of Molecular Biology (IMB), Mainz, Germany (19)
Laboratoire de Spectrométrie de Masse BioOrganique, Analytical Science department, IPHC, CNRS, Strasbourg University, UMR7178, Strasbourg, France (18)
OncoProteomics Laboratory, Dept of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands (16)
Department of Glycobiology, Institute of Chemistry, Slovak Academy of Sciences (14)
Proteomics core facility, Biomedical Research Institute, Seoul National University Hospital (14)
Proteomics Core Facility and Research Group Proteomics, CEITEC-MU, Masaryk University, Brno, Czech Republic (13)
CRUK Beatson Institute (11)
Professor of Genomic Evolution, School of Medicine, Conway Institute of Biomolecular and Biomedical Research, University College Dublin Belfield Dublin 4 (11)
Ruhr University Bochum, Germany (10)
Department of Proteomics and Signal Transduction, Max-Planck-Institute of Biochemistry, Munich, Germany (9)
The University of Sydney (9)
Baker Heart and Diabetes Institute (8)
CRUK Beatson Institute, Switchback Road, Glasgow G61 1BD, UK. (8)
Department of Biochemistry and Functional Proteomics, Institute of Biology II, Faculty of Biology and Signalling Research Centres BIOSS and CIBSS, University of Freiburg, 79104 Freiburg im Breisgau, Germany (8)
CRUK Scotland Institute for Cancer Research - Switchback Rd, Bearsden, Glasgow G61 1BD - United Kingdom (7)
Chair of Proteomics and Bioanalytics, Technische Universität München, Germany (7)
Department of Biochemistry and Molecular Biology, University of Calgary, Alberta, Canada; Department of Physiology and Pharmacology, University of Calgary, Alberta, Canada; The Hotchkiss Brain Institute, University of Calgary, Alberta, Canada; McCaig Institute for Bone and Joint Health, University of Calgary, Alberta, Canada (7)
IRCCS Istituto G Gaslini (7)
IRCCS Istituto Giannina Gaslini (7)
Institute of Biochemistry ETHZ (7)
Institute of Pharmacology and Structural Biology, CNRS, Toulouse (7)

Publication date

2021 (629)
2022 (625)
2025 (595)
2023 (571)
2024 (503)
2020 (499)
2026 (406)
2019 (398)
2018 (375)
2017 (251)
2016 (172)
2015 (99)
2014 (43)
2013 (17)
2010 (1)

Tags

xref:PubMed:37491482 (1)

Previous page
1 / 525
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 525
Next page

Sort by:

Relevance

Page size

Cassiopea andromeda

Cassiopea andromeda Targeted loci cultured

PRJNA1008071 | ENA

Cassiopea andromeda isolate:MZUSP8509

Cassiopea andromeda isolate:MZUSP8509 Genome sequencing and assembly

PRJNA576371 | ENA

Cassiopea andromeda

Cassiopea andromeda overview

PRJNA1008318 | ENA

Quantitative TMT6plex LC-MS/MS of Cassiopea andromeda

Cassiopea andromeda is an ideal species for examining antioxidant stress response by non-calcifying zooxanthellate cnidarians because unlike its sister species Cassiopea xamachana, which is geographically restricted to Florida and the West Indies, C. andromeda typically occurs in tropical and subtro...

ORGANISM(S): Cassiopea andromeda

2026-08-19 | PXD028485 | Pride